- All Journals
- Al-Qadisiyah University
- Basrah University
- Kirkuk University
- Mosul University
- The Iraqi Borad for Medical Specialization
- University of Anbar
- University of Technology
- Al Mustafa University
- Al-Zahraa University for Women
- Alnoor University
- Kunooz University
- Misan University
- Ninevah University
- Tikrit University
- University of Al-Hamdaniya
- University of Kerbala
Physiological Evaluation of Serum Meteorin-Like Protein and Fibroblast Growth Factor-21 as Biomarkers of Renal Dysfunction in Chronic Kidney Disease | ||
| Al-Kunooze Scientific Journal | ||
| Volume 12, Issue 3, July 2026, Pages 103-117 PDF (568.34 K) | ||
| Document Type: Original Article | ||
| DOI: 10.36582/ksj.2026.170737.1042 | ||
| Author | ||
| Rehab A.A. Alhamashi* | ||
| Department of Biology, College of Education for Pure Sciences, University of Wasit, Wasit, Iraq. | ||
| Abstract | ||
| Chronic kidney disease (CKD) is a progressive disorder associated with the gradual deterioration of renal function and complex metabolic disturbances. This study aimed to evaluate circulating levels of Meteorin-Like protein (METRNL) and Fibroblast Growth Factor-21 (FGF-21) and to determine their diagnostic value and association with renal function parameters in CKD patients. A total of 90 subjects were enrolled, including 60 patients with CKD and 30 healthy controls. Patients were categorized into mild-to-moderate and advanced CKD stages. Serum METRNL and FGF-21 levels were measured using ELISA, while serum creatinine, blood urea, and estimated glomerular filtration rate (eGFR) were also assessed. The results demonstrated a significant reduction in serum METRNL levels in CKD patients compared with controls, with values of 245.7 ± 71.3 pg/mL and 182.6 ± 64.9 pg/mL in CKD groups versus 312.4 ± 85.6 pg/mL in controls. In contrast, serum FGF-21 levels were significantly elevated in CKD patients, reaching 214.9 ± 62.8 pg/mL and 356.2 ± 95.4 pg/mL compared with 108.5 ± 36.7 pg/mL in controls. FGF-21 showed a positive correlation with serum creatinine (r = 0.56) and blood urea (r = 0.49), and a negative correlation with eGFR (r = −0.58). Receiver operating characteristic (ROC) analysis demonstrated good diagnostic performance for both biomarkers, with FGF-21 exhibiting superior discriminative ability (AUC = 0.88). These findings indicate that METRNL decreases, whereas FGF-21 increases with CKD progression, and both biomarkers are significantly associated with renal dysfunction parameters. The combined assessment of METRNL and FGF-21 may provide a promising biomarker panel for the diagnosis and evaluation of renal dysfunction in patients with chronic kidney disease. | ||
| Keywords | ||
| Chronic kidney disease; Meteorin-Like protein; FGF-21; renal biomarkers; eGFR | ||
|
Statistics Article View: 210 PDF Download: 92 |
||